People · Operator

Joris M Schuller, Jr., M.D.

Named in public records as an officer, director or promoter · active 2017–2023 · Other Health Care

9
Companies
11
Filings
$14.2M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
North Texas Renal Management, LLCOther Health CareSeed$8.5M$6.6M2020
North Texas Renal Management V, LLCOther Health CarePre-Seed$1.2M$384K2017
North Texas Renal Management II LLCOther Health CarePre-Seed$808K$3.0M2022
North Texas Renal Management XI, LLCOther Health CarePre-Seed$771K$1.2M2023
North Texas Renal Management VII, LLCOther Health CarePre-Seed$675K$20.8M2019
North Texas Renal Management IV, LLCOther Health CarePre-Seed$659K$20.3M2018
North Texas Renal Management IX, LLCOther Health CarePre-Seed$534K$16.5M2019
North Texas Renal Management VIII, LLCOther Health CarePre-Seed$513K$15.8M2018
North Texas Renal Management VI, LLCOther Health CarePre-Seed$489K$15.1M2018
Operator network

Joris M Schuller, Jr., M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Steven M. Gieser, M.D. · 13 companies · 8 sharedSteven M. Gieser,…Geoffrey Walker, M.D. · 9 companies · 8 sharedGeoffrey Walker, …Anupkumar M Shetty, M.D. · 8 companies · 8 sharedAnupkumar M Shett…Joris M. Schuller, M.D. · 1 companies · 1 sharedJoris M. Schuller…Richard M. Fuquay, M.D. · 1 companies · 1 sharedRichard M. Fuquay…Ruben M Velez, M.D. · 1 companies · 1 sharedRuben M Velez, M.…Ruben Velez · 1 companies · 1 sharedRuben VelezVenkata M. Yalamanchili, M.D. · 1 companies · 1 sharedVenkata M. Yalama…Ali M. Khalil, M.D. · 2 companies · 1 sharedAli M. Khalil, M.…Jyosthsna Kodali, M.D. · 1 companies · 1 sharedJyosthsna Kodali,…Daniel M. Richey, D.O. · 3 companies · 2 sharedDaniel M. Richey,…Jyothsna M. Kodali, M.D. · 3 companies · 2 sharedJyothsna M. Kodal…Geoffrey Walker · 2 companies · 1 sharedGeoffrey WalkerGeoffrey M Walker, M.D. · 5 companies · 1 sharedGeoffrey M Walker…Anupkumar Shetty · 1 companies · 1 sharedAnupkumar ShettyAnupkumar Shetty, M.D. · 1 companies · 1 sharedAnupkumar Shetty,…Daniel M. Richey · 1 companies · 1 sharedDaniel M. RicheyGeoffrey M. Walker · 1 companies · 1 sharedGeoffrey M. WalkerJoris M. Schuller · 1 companies · 1 sharedJoris M. SchullerJyothsna M. Kodali · 1 companies · 1 sharedJyothsna M. KodaliAlexander M. Liang, M.D. · 7 companies · 7 sharedAlexander M. Lian…North Texas Renal Management, LLC · $8.5M raisedNorth Texas Renal Man…North Texas Renal Management V, LLC · $1.2M raisedNorth Texas Renal Man…North Texas Renal Management II LLC · $0.8M raisedNorth Texas Renal Man…North Texas Renal Management XI, LLC · $0.8M raisedNorth Texas Renal Man…North Texas Renal Management VII, LLC · $0.7M raisedNorth Texas Renal Man…North Texas Renal Management IV, LLC · $0.7M raisedNorth Texas Renal Man…North Texas Renal Management IX, LLC · $0.5M raisedNorth Texas Renal Man…North Texas Renal Management VIII, LLC · $0.5M raisedNorth Texas Renal Man…North Texas Renal Management VI, LLC · $0.5M raisedNorth Texas Renal Man…Joris M Schuller, Jr., M.D.JM
Joris M Schuller, Jr., M.D. Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Joris M Schuller, Jr., M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Steven M. Gieser, M.D.813
Geoffrey Walker, M.D.89
Anupkumar M Shetty, M.D.88
Alexander M. Liang, M.D.77
Jyothsna M. Kodali, M.D.23
Daniel M. Richey, D.O.23
Geoffrey M Walker, M.D.15
Ali M. Khalil, M.D.12
Geoffrey Walker12
Jyothsna M. Kodali11
Geoffrey M. Walker11
Ruben Velez11
Daniel M. Richey11
Jyosthsna Kodali, M.D.11
Joris M. Schuller, M.D.11
Venkata M. Yalamanchili, M.D.11
Richard M. Fuquay, M.D.11
Ruben M Velez, M.D.11
Anupkumar Shetty, M.D.11
Anupkumar Shetty11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.